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Biology of bipolar disorder
This is a comprehensive review of biological abnormalities observed in bipolar/unipolar
mood disorders. We do not ignore that conflicting results may be found in the literature, but
attempted, nevertheless, to summarize the currents trends.
Bipolar Depression Unipolar Depression
CHALLENGE TESTS
Dexamethasone Cortisol nonsuppression
1 Cortisol nonsuppression
Hypotheses:decreased sensitivity of pituitary glucocorticoid receptors to 
dexamethasone and/or hyperresponsivity of the adrenal gland to ACTH stimulation and/or 
hypothalamic CRH hyperactivity.
Protirelin (TRH) Blunted TSH response
2,3 Blunted TSH response
Hypothesis:downregulation of pituitary TRH receptors secondary to a prolonged increase 
in endogenous TRH stimulation
Dopamine (DA) Blunted PRL response to  Normal PRL, GH, cortisol, and ACTH
apomorphine
3 response to apomorphine
Hypothesis:hyposensitivity of postsynaptic pituitary D2 receptors
Norepinephrine (NE) Blunted GH response  Blunted GH response to clonidine
to clonidine
4
Hypothesis:hyposensitivity of postsynaptic  2 adrenoreceptors
Serotonin (5-HT) The following have been found inconsistently and nonspecifically in bipolar/unipolar
depression: (i) blunted PRL and/or cortisol response to d,l- or d-fenfluramine, mCPP,
clomipramine, 5-HT1A agonists; (ii) blunted PRL and GH response to L-tryptophan
Hypothesis:decreased presynaptic 5-HT activity and/or decreased sensitivity of postsynaptic 5-HT1A receptors
MONOAMINES
Norepinephrine (NE) Low levels of urinary, plasma,  Increased urinary NE, NMN,
and CSF MHPG
5 and MHPG levels
Increased plasma NE and 
CSF MHPG levels
Hypothesis:decreased Hypothesis:increased 
presynaptic NE activity presynaptic NE activity
Serotonin (5-HT) The following have been found inconsistently and nonspecifically for
bipolar/unipolar depression: low urinary, plasma, and CSF 5-HIAA levels (dec-
creased presynaptic 5-HT activity) 
Dopamine (DA) Decreased CSF HVA levels in retarded patients (deccreased presynaptic DA activity)
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CHRONOBIOLOGY
6-8
Cortisol Desynchronization of the circadian rhythm Desynchronization of the circadian rhythm
Elevated 24-h mean plasma cortisol levels  Elevated 24-h mean plasma cortisol level
Increased number of secretory episodes Increased number of secretory episodes
Reduced amplitude of cortisol rhythm Reduced amplitude of cortisol rhythm
Delay in peak cortisol secretion Phase-advance in cortisol (and ACTH) nadir
Thyrotropin  Normal circadian profile Desynchronization of the circadian rhythm
(TSH) Normal 24-h mean plasma TSH levels Reduced 24-h mean plasma TSH levels
Normal TSH night/day ratio Reduced TSH night/day ratio
Normal nocturnal peak of TSH Absence of nocturnal peak of TSH
Prolactin  Desynchronization of the circadian rhythm Normal circadian profile or
(PRL) (advance of the nocturnal PRL elevation) advance of nocturnal PRL elevation
Reduced 24-h mean plasma PRL levels Elevated 24-h mean plasma PRL
Reduced PRL night/day ratio Hypersecretion of diurnal PRL
Lower nocturnal peak of PRL Reduced amplitude of 24-h PRL profile
Growth hormone  Desynchronization of the circadian rhythm Desynchronization of the circadian rhythm
(GH) Absence of nocturnal peak of GH Presleep peak of GH
Diurnal hypersecretion of GH Diurnal hypersecretion of GH
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receptor 2; DA, dopamine; GH, growth hormone; 5-HIAA, 5-hydroxyindoleacetic acid; 5-HT, 5-hydroxytryptamine (serotonin); 5-HT1A, 5-
hydroxytryptamine 1A receptor; HVA, homovanillic acid; mCPP, m-chlorophenylpiperazine; MHPG, 3-methoxy-4-hydroxyphenylglycol;
NMN, normetanephrine; NE, norepinephrine; PRL, prolactin; TRH, thyrotropin-releasing hormone (protirelin); TSH, thyroid-stimulating
hormone.
Poster by: Fabrice Duval, MD
FORENAP, Centre Hospitalier BP 29 , 68250 Rouffach, France (e-mail: fabrice.duval@forenap.asso.fr)